Allarity Therapeutics(ALLR)
BOSTON, MADiagnostics
Focus: Allarity Therapeutics is a Boston-based public oncology company focused on cancer treatments paired with companion diagnostics, particularly its proprietary Drug Response Predictor (DRP) platform. The company operates at the intersection of therapeutics and precision medicine diagnostics for solid tumors and hematologic malignancies.
Profile data last refreshed 13h ago · AI intelligence enriched 2mo ago
Funding Stage
PUBLIC
Open Jobs
0
About Allarity Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Allarity Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Allarity Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
4/9 — Basic
Company HealthSolid
Pipeline
Early-stage
6 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Revenue
$0K
FY2025
Pipeline & Clinical Trials
Drug Response Predictor
Ovarian CancerClinical Trials (2)
NCT03643107Irofulven in AR-targeted and Docetaxel-Pretreated mCRPC Patients With Drug Response Predictor (DRP®)
Phase 2Help build intelligence for Allarity Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.